These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 7914685

  • 1. Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors.
    Vaccarino FJ.
    Neurosci Biobehav Rev; 1994; 18(2):207-14. PubMed ID: 7914685
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
    Vaccarino FJ, Rankin J.
    Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
    [Abstract] [Full Text] [Related]

  • 8. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA, Hope O, Okonji C, Rahni DN, Zhou Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of dopamine in the nucleus accumbens in analgesia.
    Altier N, Stewart J.
    Life Sci; 1999 Jan; 65(22):2269-87. PubMed ID: 10597883
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of intra-accumbens dopaminergic grafts on behavioral deficits induced by 6-OHDA lesions of the nucleus accumbens or A10 dopaminergic neurons: a comparison.
    Herman JP, Choulli K, Abrous N, Dulluc J, Le Moal M.
    Behav Brain Res; 1988 Jul; 29(1-2):73-83. PubMed ID: 3401324
    [Abstract] [Full Text] [Related]

  • 14. Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats.
    Narita M, Takagi M, Aoki K, Kuzumaki N, Suzuki T.
    J Neurochem; 2003 Jul; 86(2):273-82. PubMed ID: 12871568
    [Abstract] [Full Text] [Related]

  • 15. Cholecystokinergic innervation of nucleus accumbens subregions.
    Lança AJ, De Cabo C, Arifuzzaman AI, Vaccarino FJ.
    Peptides; 1998 Jul; 19(5):859-68. PubMed ID: 9663451
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN, Stivers JA, Hommer DW, Skirboll LR, Paul SM.
    J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiological effects of cholecystokinin: central dopaminergic systems.
    Wang RY, White FJ.
    Prog Clin Biol Res; 1985 Feb; 192():95-103. PubMed ID: 4080721
    [Abstract] [Full Text] [Related]

  • 19. Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.
    Rotzinger S, Vaccarino FJ.
    J Psychiatry Neurosci; 2003 May; 28(3):171-81. PubMed ID: 12790157
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.